Product Description
Docetaxel Injection IP 120mg is a chemotherapy drug used to treat many types of cancer, including breast, ovarian, lung, prostate, and head and neck cancer. It is given intravenously (into a vein). It works by interfering with the growth of cancer cells. It is usually given in combination with other drugs. The most common side effects are low white blood cell count, hair loss, nausea, and vomiting.
Ready-to-Use Sterile FormulationDocetaxel Injection IP 120mg comes in a convenient, pre-formulated solution, eliminating the need for reconstitution. This reduces preparation time and minimizes the risk of handling errors, providing an efficient and reliable treatment option for healthcare professionals. Its clear, colorless to pale yellow appearance confirms its integrity and purity.
Comprehensive Cancer Treatment IndicationsWidely utilized as an antineoplastic agent, Docetaxel Injection is indicated for several malignancies, including breast, non-small cell lung, prostate, gastric, and head & neck cancers. Its proven efficacy across these cancer types makes it a versatile therapeutic choice for oncologists.
Stringent Safety and Handling PrecautionsDue to its cytotoxic nature, Docetaxel Injection demands careful handling. It must only be administered by trained professionals using protective equipment. Regular monitoring of neutrophil counts and vigilance for hypersensitivity reactions are essential during therapy. The product is further safeguarded by glass vial packaging with aluminum seals.
FAQs of Docetaxel Injection IP 120mg:
Q: How is Docetaxel Injection IP 120mg administered?
A: Docetaxel Injection IP 120mg is administered exclusively via intravenous infusion. The solution must be further diluted using 0.9% sodium chloride or 5% dextrose before being infused over one hour by a healthcare professional.
Q: What are the therapeutic indications for Docetaxel Injection IP 120mg?
A: This injection is indicated for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head & neck cancer, serving as an effective antineoplastic agent in these conditions.
Q: When should Docetaxel Injection not be used?
A: Docetaxel Injection should not be used in patients with hypersensitivity to docetaxel or polysorbate 80, or those with a neutrophil count below 1500/mm. Always check for contraindications prior to administration.
Q: What are the steps for preparing Docetaxel Injection for infusion?
A: No reconstitution is required as the product is supplied as a ready-to-use solution. It should be further diluted with 0.9% sodium chloride or 5% dextrose before administration, resulting in a clear, colorless to pale yellow solution.
Q: Where should Docetaxel Injection IP 120mg be stored?
A: Store the vials below 25C, protected from light, and do not freeze. These storage conditions help maintain product stability and efficacy for up to 24 months.
Q: What handling precautions should be taken during preparation and administration?
A: This medication is cytotoxic, so personnel must wear protective equipment such as gloves and gowns when preparing or administering the injection to prevent accidental exposure.
Q: What are the benefits of using this formulation?
A: Docetaxel Injection IP 120mg offers a highly purified, ready-to-use sterile formulation that simplifies preparation, reduces contamination risks, and ensures accurate dosing for effective cancer therapy.